Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 19935662 | HLA IDENTICAL (HLA-IDENTICAL) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| one such disease, graft-versus-host disease (gvhd) after hematopoietic stem cell transplantation (hsct, or bone marrow transplant), is common even after transplants between hla-identical siblings, indicating that cryptic histocompatibility loci exist outside the hla locus. | |||||||
| 19935662 | HLA IDENTICAL (HLA-IDENTICAL) | disease, graft-versus-host | NA | NA | NA | unclassified | |
| one such disease, graft-versus-host disease (gvhd) after hematopoietic stem cell transplantation (hsct, or bone marrow transplant), is common even after transplants between hla-identical siblings, indicating that cryptic histocompatibility loci exist outside the hla locus. | |||||||
| 19968064 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| [effects of killer immunoglobulin-like receptor and human leukocyte antigen class i ligand on the prognosis of related donor hematopoietic stem cell transplantation]. | |||||||
| 19968064 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| to study the genotype distribution and the effects of killer immunoglobulin-like receptors (kir) and human leukocyte antigen (hla) class i ligand on related donor hematopoietic stem cell transplantation (hsct). | |||||||
| 20160060 | HLA-A*02 | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| novel hla a*0201-restricted hy epitopes can be predicted and validated in patients after allogeneic hematopoietic stem cell transplantation. | |||||||
| 20439202 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| nonmyeloablative allogeneic hematopoietic stem cell transplantation may provide the best opportunity for cure following remission if a human leukocyte antigen-matched hematopoietic stem cell donor is available. | |||||||
| 20508480 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | positive | |
| we report on an adolescent female who failed to respond to induction immunochemotherapy and was salvaged by allogeneic hematopoietic stem cell transplantation from her human leukocyte antigen-identical, epstein-barr virus-seropositive brother leading to rapid clearance of epstein-barr virus from blood and cerebrospinal fluid. | |||||||
| 20561441 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| this study was aimed to investigate the role of sequence similar matching (ssm) method in prediction of gvhd after hla unmatched allogeneic hematopoietic stem cell transplantation (allo-hsct). | |||||||
| 20561441 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| in conclusion, the ssm method can be used to predict gvhd in the hla-unmatched allogeneic hematopoietic stem cell transplantation. | |||||||
| 20561455 | HLA IDENTICAL (HLA-IDENTICAL) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| [relationship of alloreactive nk cells to prognosis of hla-identical sibling allogeneic hematopoietic stem cell transplantation]. | |||||||
Copyright 2024